Nebulized Ceftazidime and Amikacin in Ventilator-Associated Pneumonia Caused byPseudomonas Aeruginosa

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.201011-1894oc
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa

Critical Care Medicine
Critical CareIntensive Care Medicine
2012English

Inhaled Ceftazidime and Amikacin Versus Inhaled Colistin in the Treatment of Gram Negative Ventilator Associated Pneumonia

Intensive Care Medicine Experimental
Critical CareIntensive Care Medicine
2015English

Ventilator-Associated Pneumonia Caused by Dolosigranulum Pigrum

Journal of Clinical Microbiology
Microbiology
2006English

Pseudomonas Aeruginosa Colonization Enhances Ventilator-Associated Pneumonia-Induced Lung Injury

Respiratory Research
PulmonaryRespiratory Medicine
2016English

Ventilator-Associated Pneumonia

Perspectives on Critical Care Infectious Diseases
2001English

Ventilator-Associated Pneumonia

The Professional Medical Journal
2018English

Ventilator-Associated Pneumonia

Respirology
PulmonaryRespiratory Medicine
2009English

Population Pharmacokinetics of Single-Dose Amikacin in Critically Ill Patients With Suspected Ventilator-Associated Pneumonia

European Journal of Clinical Pharmacology
MedicinePharmacology
2014English

Efficacy of Amikacin and Ceftazidime in Experimental Aortic Valve Endocarditis Due to Pseudomonas Aeruginosa.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy